Biomarker and Companion Diagnostics Conference

5th - 6th October 2023

Frankfurt, Germany

Discovering the latest technologies and biomarkers that drive translational research and precision medicine.

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 5th-6th October 2023 in Frankfurt, Germany. This event is designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.

This conference unites advances in biomarker use for drug discovery and development, alongside biomarkers for cancer. The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.


  • Commercialization of CDx
  • Proteomics and Genomics based Biomarkers.
  • Biomarker Drug Discovery and Assay Development
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine, and Big Data
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology, and Inflammatory Diseases

  • Hear from and meet with the key industry and academic innovators in biomarkers, translational medicine, clinical development, and diagnostics.
  • Discover the latest integration of biomarkers in early drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, cardiology, immunology respiratory rare diseases, and cell and gene therapies.
  • Gain novel insights into key biomarkers for detection, monitoring, and diagnosis, including innovative applications of digital markers.
  • Benefit from case studies on topical technology innovation within digital pathology, AI & imaging, flow cytometry, multiplexing, mass spectrometry and spatial biology tools.
  • Unparalleled networking opportunities. The two-day congress offers an interactive platform for high-level scientific and business discussions. Participate in formal or informal discussions during our networking breaks and pre-organised 1-2-1 meetings.

Researchers, scientists, clinicians, academicians and professionals from pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers




Frankfurt, Germany